Susquehanna International Group, LLP Myovant Sciences Ltd. Transaction History

Susquehanna International Group, LLP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$24.03 - $27.02 $8.3 Million - $9.34 Million	-345,550 Reduced 93.1%	25,615 $690,000
Q3 2022 Nov 14, 2022	BUY	$11.6 - $20.44 $1.3 Million - $2.29 Million	112,135 Added 43.29%	371,165 $6.67 Million
Q2 2022 Aug 15, 2022	SELL	$7.78 - $14.69 $1.81 Million - $3.42 Million	-232,654 Reduced 47.32%	259,030 $3.22 Million
Q1 2022 May 16, 2022	SELL	$11.38 - $16.4 $1.17 Million - $1.69 Million	-103,010 Reduced 17.32%	491,684 $6.55 Million
Q4 2021 Feb 14, 2022	BUY	$14.31 - $23.87 $6.26 Million - $10.4 Million	437,449 Added 278.2%	594,694 $9.26 Million
Q3 2021 Nov 15, 2021	SELL	$18.94 - $26.99 $1.42 Million - $2.03 Million	-75,222 Reduced 32.36%	157,245 $3.53 Million
Q2 2021 Aug 11, 2021	SELL	$17.07 - $24.56 $973,246 - $1.4 Million	-57,015 Reduced 19.7%	232,467 $5.29 Million
Q1 2021 May 17, 2021	BUY	$20.46 - $25.18 $1.31 Million - $1.61 Million	63,928 Added 28.34%	289,482 $5.96 Million
Q4 2020 Feb 16, 2021	SELL	$13.8 - $27.62 $1.32 Million - $2.64 Million	-95,611 Reduced 29.77%	225,554 $6.23 Million
Q3 2020 Nov 16, 2020	SELL	$14.05 - $22.6 $208,277 - $335,022	-14,824 Reduced 4.41%	321,165 $4.51 Million
Q2 2020 Aug 14, 2020	BUY	$7.34 - $20.84 $2.29 Million - $6.51 Million	312,427 Added 1325.98%	335,989 $6.93 Million
Q1 2020 May 15, 2020	BUY	$6.55 - $14.76 $154,331 - $347,775	23,562 New	23,562 $178,000

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.